Initiation of antiretroviral therapy (ART) at different stages of HIV-1 disease is not associated with the proportion of exhausted CD8+ T Cells

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Jensen, Sanne Skov ^a,b,c   Fomsgaard, Anders ^a,c   Larsen, Tine Kochendorf ^a   Tingstedt, Jeanette Linnea ^a   Gerstoft, Jan ^d   Kronborg, Gitte ^d   Pedersen, Court ^b   Karlsson, Ingrid ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD160 ANTIGEN; CYTOCHROME P450 2B4; GAMMA INTERFERON; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE FUNCTION; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; YOUNG ADULT; CASE CONTROL STUDY; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84947221904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139573     Document Type: Article

References (34)

1. Yewdell JW. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity. 2006; 25(4):533-43. doi: 10.1016/j.immuni.2006.09.005.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of virology. 1994; 68(9):6103-10.
3. Matano T, Kobayashi M, Igarashi H, Takeda A, Nakamura H, Kano M, et al. Cytotoxic T lymphocytebased control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. The Journal of experimental medicine. 2004; 199(12):1709-18. doi: 10.1084/jem.20040432
4. Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nature reviews Immunology. 2004; 4(8):630-40. doi: 10.1038/nri1417.
5. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 Tcell immunodominance and tissue distribution and results in distinct stages of functional impairment. Journal of virology. 2003; 77(8):4911-27.
6. Fuller MJ, Zajac AJ. Ablation of CD8 and CD4 T cell responses by high viral loads. J Immunol. 2003; 170(1):477-86.
7. Ou R, Zhou S, Huang L, Moskophidis D. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. Journal of virology. 2001; 75(18):8407-23.
8. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006; 443 (7109):350-4.
9. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006; 439(7077):682-7. Epub 2005/12/31. doi: 10.1038/nature04444.
10. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature immunology. 2009; 10 (1):29-37. doi: 10.1038/ni.1679
11. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson MA, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS pathogens. 2014; 10(7):e1004251. doi: 10.1371/journal.ppat.1004251
12. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS pathogens. 2010; 6(6):e1000947. doi: 10.1371/journal.ppat.1000947
13. Vigano S, Banga R, Bellanger F, Pellaton C, Farina A, Comte D, et al. CD160-Associated CD8 T-cell functional impairment is independent of PD-1 expression. PLoS pathogens. 2014; 10(9):e1004380. doi: 10.1371/journal.ppat.1004380
14. Benlhassan-Chahour K, Penit C, Dioszeghy V, Vasseur F, Janvier G, Riviere Y, et al. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy. Journal of virology. 2003; 77(23):12479-93.
15. Malleret B, Maneglier B, Karlsson I, Lebon P, Nascimbeni M, Perie L, et al. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood. 2008; 112(12):4598-608. doi: 10.1182/blood-2008-06-162651.
16. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. The New England journal of medicine. 2013; 368(3):218-30. doi: 10.1056/NEJMoa1110187
17. Hocqueloux L, Prazuck T, Avettand-Fenoel V, Lafeuillade A, Cardon B, Viard JP, et al. Long-Term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS. 2010; 24(10):1598-601.
18. Fomsgaard A, Vinner L, Therrien D, Jorgensen LB, Nielsen C, Mathiesen L, et al. Full-length characterization of A1/D intersubtype recombinant genomes from a therapy-induced HIV type 1 controller during acute infection and his noncontrolling partner. AIDS research and human retroviruses. 2008; 24 (3):463-72. doi: 10.1089/aid.2006.0294.
19. Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, et al. Post-Treatment HIV-1 controllers with a long-Term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS pathogens. 2013; 9(3):e1003211. doi: 10.1371/journal.ppat.1003211
20. Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS pathogens. 2014; 10(12):e1004543. doi: 10.1371/journal.ppat.1004543
21. Cellerai C, Harari A, Stauss H, Yerly S, Geretti AM, Carroll A, et al. Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-Term non-progressors. PloS one. 2011; 6(4):e18164. doi: 10.1371/journal.pone.0018164
22. Brandt L, Benfield T, Kronborg G, Gerstoft J, Fomsgaard A, Karlsson I. HIV-1-infected individuals in antiretroviral therapy react specifically with polyfunctional T-cell responses to Gag p24. J Acquir Immune Defic Syndr. 2013; 63(4):418-27. doi: 10.1097/QAI.0b013e31828fa22b.
23. Yamamoto T, Price DA, Casazza JP, Ferrari G, Nason M, Chattopadhyay PK, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood. 2011; 117(18):4805-15. doi: 10.1182/blood-2010-11-317297
24. Jensen SS, Hartling HJ, Tingstedt JL, Larsen TK, Nielsen SD, Pedersen C, et al. HIV-specific ADCC improves after antiretroviral therapy and correlates with normalization of the NK cell phenotype. J Acquir Immune Defic Syndr. 2014. doi: 10.1097/QAI.0000000000000429.
25. Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol. 2003; 171(1):477-88.
26. Casazza JP, Betts MR, Picker LJ, Koup RA. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. Journal of virology. 2001; 75(14):6508-16. doi: 10.1128/JVI.75.14.6508-6516.2001
27. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. The Journal of experimental medicine. 2009; 206(6):1253-72. doi: 10.1084/jem.20090365
28. Turnbull EL, Wong M, Wang S, Wei X, Jones NA, Conrod KE, et al. Kinetics of expansion of epitopespecific T cell responses during primary HIV-1 infection. J Immunol. 2009; 182(11):7131-45. doi: 10.4049/jimmunol.0803658.
29. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nature protocols. 2010; 5(6):1033-41. doi: 10.1038/nprot.2010.73.
30. Lopez M, Soriano V, Rallon N, Cascajero A, Gonzalez-Lahoz J, Benito JM. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8 (+) T cells. European journal of immunology. 2008; 38(6):1548-58. doi: 10.1002/eji.200738054.
31. Akinsiku OT, Bansal A, Sabbaj S, Heath SL, Goepfert PA. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression. J Acquir Immune Defic Syndr. 2011; 58(2):132-40. doi: 10.1097/QAI.0b013e318224d2e9
32. Saez-Cirion A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: Association with Gag-specific CD8 T cell responses. J Immunol. 2009; 182(12):7828-37. Epub 2009/06/06. doi: 10.4049/jimmunol.0803928.
33. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-9.
34. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. The Journal of experimental medicine. 2007; 204(10):2473-85. doi: 10.1084/jem.20070784f